Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
You’ll instantly connect to the latest in global medtech developments with industry news, trends, deals, product developments, opinions, analysis, and context behind the headlines and more – all available at your fingertips.
Create your business-building strategy with Medtech Insight. Get the latest medical technology news and expert opinion on product developments, investment trends, deals, and shifts in industry dynamics, gaining insight into the evolving breakthrough medical technologies that will impact the industry. Plus, keep on top of regulatory changes and policy issues to see how these will impact the industry. Stay in touch with what your competitors are up to with news about manufacturing and approvals.
How it helps
Medtech Insight gives you quality news and insight into medical technologies in surgical, orthopedic, cardiovascular, and other markets.
How it works
As a subscriber, you’ll enjoy any-time, any-device access to the industry’s critical thinkers and opinion leaders. You’ll also receive access to Medtech Insight trackers, which monitor M&A and venture capital financing deals, product approvals, global regulatory guidance documents, US legislation, and US FDA warning letters.
Global content from trusted experts
More than a dozen experienced journalists and analysts based in Europe, US, and Asia bring you real-time analysis, news and opinion across the medtech landscape – covering regulatory, product and company developments.
Medtech Insight
A $2.2tn coronavirus stimulus package signed into law by President Trump on 27 March will distribute billions of dollars to federal agencies – including the FDA, the CDC and the FEMA – to hasten approvals of new diagnostics, medical ventilators, respirators and other medtech supplies, conduct more testing of potential COVID-19 patients, and quickly distribute medical supplies where needed most.
Topic Coronavirus
Medtech Insight
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
Topic Coronavirus Medtech
Medtech Insight
Medtech Insight is tracking the IVD companies manufacturing tests for SARS-CoV-2, the coronavirus that causes COVID-19.
Topic Coronavirus
Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet...
Access the infographic below which explores the number of treatment drugs for COVID-19 currently in clinical trials or in development, events including progress updates, partnerships, regulatory and trial announcements etc, and the number of articles published on COVID-19 as of March 3, 2020. This data has been tracked and reported via Informa Pharma Intelligence’s clinical, regulatory and commercial data and analytics, and news and insight tools including Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet, Medtech Insight, and Generics Bulletin etc.
Topic Coronavirus
Medtech Insight
The US agency says it will not object to medtech manufacturers making minor modifications to the motors, tubing or software of medical ventilators – or even to pressing CPAP (continuous positive airway pressure) equipment into service to use as ventilators – during the COVID-19 public health emergency.
Topic Coronavirus Medtech
Medtech Insight
US telehealth companies are seeing skyrocketing demand for devices and services, which offers opportunities and challenges during this COVID-19 crisis.
Topic Coronavirus Medtech
Medtech Insight
A rapid-response test from Danaher business unit Cepheid will be the first quick COVID-19 diagnostic to reach the US market, the US FDA announced on 21 March.
Topic Coronavirus Medtech
In Vivo, HBW Insight, Pink Sheet, Scrip, Generics Bulletin, ...
Track the latest developments in the worldwide coronavirus outbreak and what it means for the pharma, medtech, generics and OTC industries with coverage from the Informa Pharma Intelligence Insights suite of tools. Get vital breaking news and penetrating analysis about the impact of this global health crisis.
Topic Coronavirus
Medtech Insight
Two Hogan Lovells attorneys say the medical device industry is jittery about President Trump’s 18 March invocation of the Defense Production Act. That’s because the DPA gives the government broad authority to, among other things, order manufacturers to make particular products in a time of great national need. That can be a problem if those companies can’t make complex products like ventilators – or don’t make devices in the first place. After all, “we’re not making hubcaps. We’re making important devices,” Hogan Lovells partner Mike Heyl tells Medtech Insight.Is Making Industry Sweat.
Topic Coronavirus Medtech
Medtech Insight
US health systems are canceling elective surgeries in response to COVID-19 to preserve critical resources. Massachusetts General Hospital works with medtechs to find technological solutions to keep patients and caregivers safe.
Topic Coronavirus
Medtech Insight
The UK is near the bottom of the European ranking of ICU beds available, with just 6.6 per 100,000 – and it has just 5,000 ventilators. The COVID-19 crisis is demanding a response that many are comparing to a war effort.
Topic Coronavirus
Medtech Insight
An $8.3bn “Coronavirus Preparedness and Response Supplemental” funding act approved by the US Congress last week and signed into law on 6 March provides dollars and lays out the roles federal agencies, such as the FDA, and state and local agencies must play in containing and controlling the spread of COVID-19.
Topic Coronavirus
Medtech Insight
A recent US FDA webinar offered insights on the technical challenges developers face in trying to get COVID-19 diagnostics to US patients.
Topic Coronavirus
Medtech Insight
In a late Friday news statement, agency head Stephen Hahn also warned of possible “shortages of critical medical products” The US agency has suspended all routine surveillance inspections in China through the end of March because of coronavirus fears, commissioner Stephen Hahn announced late on 14 February. Despite expecting medical product shortages, Hahn said the agency is being proactive: “We are not waiting for drug and device manufacturers to report shortages to us” before acting. The timing of Hahn’s statement – at 6 p.m. EST on a Friday, at the beginning of a three-day US holiday weekend – suggests he isn’t particularly excited to share the information.
Topic Coronavirus
Medtech Insight
The FDA has readied plans for hastened emergency-use approvals of coronavirus test kits after an infected US citizen returned to Washington State from Wuhan province in China. See what the FDA’s Megan McSeveney said about it here.
Topic Drug approval Coronovirus FDA
Medtech Insight
03 Apr 2020
Medtech Insight
03 Apr 2020
Medtech Insight
03 Apr 2020
Medtech Insight
03 Apr 2020
Medtech Insight
03 Apr 2020
Medtech Insight
03 Apr 2020
Medtech Insight
03 Apr 2020
Medtech Insight
02 Apr 2020
Medtech Insight
02 Apr 2020
Medtech Insight
02 Apr 2020
Medtech Insight
02 Apr 2020
Medtech Insight
02 Apr 2020
Medtech Insight
02 Apr 2020
Medtech Insight
02 Apr 2020
Medtech Insight
02 Apr 2020
UK
Amanda specializes in
+36 year(s) experience
UK
Neena specializes in
+33 year(s) experience
Japan
Ian specializes in
+32 year(s) experience
Get a window into what the leading players across the biopharma, medtech, and diagnostics industries are thinking, as well as important insight into what your competitors are doing. Build your strategy with In Vivo.
In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.
Looking for more products Product Finder
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
